Onderneming Critical Outcome Technologies Inc. Toronto S.E.
Aandelen
COT
CA22675B1031
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- CAD | - |
|
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 01-01-15 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 12-06-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 01-07-18 | |
John C. Drake
CHM | Chairman | - | 20-02-07 |
Alison D. Silva
PSD | President | 46 | 01-01-15 |
David Sanderson
BRD | Director/Board Member | - | 05-12-13 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 21 986 415 | 15 211 245 ( 69,18 %) | 0 | 69,18 % |
Bedrijfsgegevens
Cotinga Pharmaceuticals, Inc.
127 Main Street
02129, Boston
+
![Adres Critical Outcome Technologies Inc.(COT)](https://cdn.zonebourse.com/static/address/17053456.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,63% | 127 mld. | |
+23,21% | 117 mld. | |
+25,56% | 27,67 mld. | |
-20,17% | 20,33 mld. | |
-16,68% | 16,79 mld. | |
-18,07% | 15,63 mld. | |
+11,92% | 14,84 mld. | |
-47,70% | 14,65 mld. | |
+58,32% | 14,43 mld. |
- Beurs
- Aandelen
- Koers COTQF
- Koers COT
- Onderneming Critical Outcome Technologies Inc.